Reconstitution Steps

1. Draw 3.0 mL bacteriostatic water with a sterile syringe.

2. Inject slowly down the vial wall; avoid foaming.

3. Gently swirl/roll until dissolved (do not shake).

4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

5. Refrigerated Storage Up To 90 Days

Syringe Math Reference

With 3.0 mL reconstitution volume and 80 mg total peptide:

• Total concentration: 26.67 mg/mL (26,667 mcg/mL)

• TB-500: 3.33 mg/mL → 33.3 mcg per unit

• BPC-157: 3.33 mg/mL → 33.3 mcg per unit

• KPV: 3.33 mg/mL → 33.3 mcg per unit

• GHK-Cu: 16.67 mg/mL → 166.7 mcg per unit

• 1 unit (0.01 mL) = 33.3 mcg each of TB-500, BPC-157, KPV + 166.7 mcg GHK-Cu

Dosing Protocol

Suggested daily titration approach.

• Start: 7.5 units daily (0.075 mL) for initial assessment period.

• Increase: Progress to 15 units by Week 3, then 22.5 units by Week 5 as tolerated.

• Maintenance: 15 units daily for extended protocols.

• Frequency: Once per day (subcutaneous).

• Cycle Length: 8–12 weeks; optional extension to 16 weeks.

• Timing: Any consistent time; rotate injection sites.

Important Notes

Practical considerations for consistency and safety.

• Use new sterile insulin syringes for each injection; dispose in a sharps container.

• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.

• Inject slowly; wait a few seconds before withdrawing the needle.

• Document daily dose and site rotation to maintain consistency.

• This multi-peptide blend may provide broader regenerative support than single-peptide protocols.

How This Works

KLOW combines four peptides with complementary mechanisms of action:

• TB-500 (Thymosin Beta-4): Promotes angiogenesis, cell migration, and tissue repair by regulating actin, a key protein in cell structure. Preclinical studies demonstrate accelerated wound healing, reduced inflammation, and tissue regeneration.

• BPC-157: A gastric pentadecapeptide that supports tendon, ligament, and muscle healing through enhanced angiogenesis and growth factor modulation. Animal studies show favorable tissue repair outcomes.

• KPV: A C-terminal tripeptide fragment of α-MSH with potent anti-inflammatory properties. It inhibits NF-κB signaling and reduces pro-inflammatory cytokines without melanotropic effects.

• GHK-Cu: A naturally occurring copper peptide that stimulates collagen and elastin synthesis, promotes wound healing, and modulates gene expression related to tissue remodeling.

Potential Benefits & Side Effects

Observations from preclinical and early-stage research.

Potential Benefits

• Accelerated tissue repair and wound healing through multiple complementary pathways.

• Reduced inflammation via NF-κB inhibition and cytokine modulation.

• Enhanced collagen synthesis and connective tissue support.

• Promotion of angiogenesis and improved blood flow to healing tissues.

• Potential support for musculoskeletal recovery and joint health.

Possible Side Effects

• Mild injection-site reactions (redness, irritation) may occur with subcutaneous administration.

• Occasional lightheadedness reported with some peptides due to vasodilatory effects.

• Limited human clinical data; most safety observations derive from preclinical studies.

Lifestyle Factors

Complementary strategies for best outcomes.

• Pair with a balanced, protein-forward diet tailored to support tissue repair and recovery.

• Combine resistance training and mobility work to reinforce musculoskeletal adaptations.

• Prioritize sleep and stress management to optimize the body’s natural regenerative processes.

• Stay well-hydrated to support peptide absorption and overall metabolic function.

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

• Clean the vial stopper and skin with alcohol; allow to dry completely.

• Pinch a skin fold; insert the needle at 45–90° into subcutaneous tissue.

• Do not aspirate for subcutaneous injections; inject slowly and steadily.

• Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.

• Apply gentle pressure after withdrawal; do not massage the injection site.